Related Experiment Video
Updated: Aug 1, 2025

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
Synthetic lethality prediction in DNA damage repair, chromatin remodeling and the cell cycle using multi-omics data
Magda Markowska1,2, Magdalena A Budzinska1,3, Anna Coenen-Stass4
1Faculty of Mathematics, Informatics and Mechanics, University of Warsaw, Stefana Banacha 2, 02-097, Warsaw, Poland.
Abstract:
Discovering synthetic lethal (SL) gene partners of cancer genes is an important step in developing cancer therapies. However, identification of SL interactions is challenging, due to a large number of possible gene pairs, inherent noise and confounding factors in the observed signal. To discover robust SL interactions, we devised SLIDE-VIP, a novel framework combining eight statistical tests, including a new patient data-based test iSurvLRT. SLIDE-VIP leverages multi-omics data from four different sources: gene inactivation cell line screens, cancer patient data, drug screens and gene pathways. We applied SLIDE-VIP to discover SL interactions between genes involved in DNA damage repair, chromatin remodeling and cell cycle, and their potentially druggable partners. The top 883 ranking SL candidates had strong evidence in cell line and patient data, 250-fold reducing the initial space of 200K pairs. Drug screen and pathway tests provided additional corroboration and insights into these interactions. We rediscovered well-known SL pairs such as RB1 and E2F3 or PRKDC and ATM, and in addition, proposed strong novel SL candidates such as PTEN and PIK3CB. In summary, SLIDE-VIP opens the door to the discovery of SL interactions with clinical potential. All analysis and visualizations are available via the online SLIDE-VIP WebApp.
Insights
We developed SLIDE-VIP, a new computational framework to identify synthetic lethal (SL) gene interactions for cancer therapy. This method significantly reduces candidate pairs, uncovering potential drug targets from complex biological data.
Area of Science:
- Computational Biology
- Genomics
- Cancer Research
Background:
- Identifying synthetic lethal (SL) gene interactions is crucial for developing targeted cancer therapies.
- Challenges include the vast number of gene pairs and data noise, hindering robust discovery.
Purpose of the Study:
- To introduce SLIDE-VIP, a novel framework for discovering robust SL gene interactions.
- To leverage multi-omics data for enhanced identification of clinically relevant SL pairs.
Main Methods:
- SLIDE-VIP integrates eight statistical tests, including a new patient data-based test (iSurvLRT).
- Utilizes multi-omics data from cell line screens, patient data, drug screens, and gene pathways.
- Applied to identify SL interactions among DNA repair, chromatin remodeling, and cell cycle genes.
Main Results:
- Reduced the search space from 200,000 to 883 high-confidence SL candidates.
- Validated known SL pairs (e.g., RB1-E2F3, PRKDC-ATM) and proposed novel candidates (e.g., PTEN-PIK3CB).
- Drug screen and pathway analyses provided corroboration and biological insights.
Conclusions:
- SLIDE-VIP effectively identifies SL interactions with significant clinical potential.
- The framework facilitates the discovery of novel therapeutic targets in cancer.
- Analysis and visualizations are accessible via the SLIDE-VIP WebApp.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
Fixing Double-strand Breaks
DNA Damage Can Stall the Cell Cycle
Overview of DNA Repair
Chemically...
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Genomics

